How should immune hemolytic anemia be treated?
Immune hemolytic anemia can be managed through general treatment, drug therapy, and surgical intervention. The specific approaches are as follows:
1. General Treatment
General treatment measures include rest, dietary management, and maintaining adequate fluid intake. During treatment, patients should avoid factors such as fatigue, infections, and emotional fluctuations to prevent triggering a hemolytic crisis.
2. Drug Therapy
Most patients with immune hemolytic anemia require medication under medical supervision to control hemolysis and increase hemoglobin levels. Commonly used medications include corticosteroids, immunosuppressants, and monoclonal antibodies, such as dexamethasone tablets and prednisolone acetate injection.
3. Surgical Treatment
Surgical intervention is typically reserved for rare cases, such as severe hemolytic crisis or when drug therapy fails. Common procedures include splenectomy and hematopoietic stem cell transplantation.
In summary, immune hemolytic anemia is a complex disease requiring individualized treatment plans. Early diagnosis, prompt treatment, and ongoing monitoring are key to preventing complications and improving survival rates.